Poltreg S.A.

Poltreg S.A. company information, Employees & Contact Information

Explore related pages

Related company profiles:

PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. PolTREG is the most advanced company in TREGS cellular therapies worldwide, breakthrough therapies for type 1 diabetes (T1D) and multiple sclerosis (MS). PolTREG has very promising results regarding the safety and efficacy of TREGS therapy (completed phase I/II clinical trials in T1D and phase I in MS), ready for the next phase of trials. The company is after EMA Scientific Advice procedure.

Company Details

Employees
40
Founded
-
Address
Ul. Botaniczna 20, Gdańsk,pomorskie 80-298,poland
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Gdańsk, Pomorskie
Looking for a particular Poltreg S.A. employee's phone or email?

Poltreg S.a. Questions

News

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007 - BioSpace

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007 BioSpace

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy - GlobeNewswire

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy GlobeNewswire

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial - Yahoo! Finance UK

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial Yahoo! Finance UK

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes - GlobeNewswire

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes GlobeNewswire

PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland - Yahoo Finance

PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland Yahoo Finance

PolTREG Treg cell therapy for patients with type-1 diabetes - GlobeNewswire

PolTREG Treg cell therapy for patients with type-1 diabetes GlobeNewswire

PolTREG appoints Dan Shelly as Chief Business Development Officer - GlobeNewswire

PolTREG appoints Dan Shelly as Chief Business Development Officer GlobeNewswire

Top Poltreg S.A. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant